Low Testosterone

Low Testosterone (Low T) Therapy

What is Andropause?

Andropause, or male menopause (“man-opause”) is the name given to the gradual drop in testosterone that typically affects men between the ages of 40 and 55 but may be seen as  early as 25. Low testosterone, also known as hypogonadism, affects an estimated 13 million men in the U.S.

This decline in male hormones is a natural phenomenon; no man can avoid it. Due to lifestyle factors including stress, poor diet, a lack of physical activity and poor sleep habits, more men under 40 are affected by low testosterone levels.

When a man’s testosterone levels are low, he may experience the following symptoms:

  • Decreased muscle and strength
  • Depression
  • Declining ability to concentrate
  • Lack of energy
  • Low libido
  • Poor sleep
  • Weak erections

If you experience one or more of the above symptoms, we encourage you to contact us today to schedule a consultation.

There are three primary methods of treatment used for low testosterone (Low T) therapy. They include:

1. Bio Identical Pellet Therapy (BioTe)

2. Daily Transdermal gels (Androgel, Axiron, Testim, Fortesta)

3. Injectable Testosterone


1. Insurance option:

Insurance typically covers hormone replacement therapies. FMTNX accepts most insurances.

2. Cash option:

$100- Establishment visit for new patients

$50- testosterone booster injection (typically every 7-14 days/medication is included)

$100- Lab work (Labs must be completed prior to testosterone therapy initiation, 3 months after initiation, then every 6 months once satisfactory testosterone levels are achieved.

To learn more about BioTe Pellets visit www.mymedicareclinic.com.

Patients with a history of the following should avoid testosterone replacement therapy:

  • Breast or prostate cancer
  • Erythrocytosis
  • Untreated obstructive sleep apnea
  • Uncontrolled severe heart failure
  • Unexplained PSA elevation
  • Severe lower urinary tract symptoms associated with benign prostatic hypertrophy
  • Unstable severe congestive heart failure (class III or IV)